Your session is about to expire
← Back to Search
Melatonin for Delirium (MIND Trial)
MIND Trial Summary
This trial is testing whether melatonin can decrease the incidence of postoperative delirium in elderly patients.
MIND Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMIND Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MIND Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am older than 65 years.I cannot take medications by mouth.I am not willing to participate in the trial.My liver enzyme (ALT) level is above 500 IU/L.You cannot speak the language used in the study.I am scheduled for a major surgery that is not heart-related and will be in the hospital for at least 2 days.I am currently taking melatonin.You currently have a serious problem with confusion or memory loss.You are allergic to melatonin.You have participated in a previous study.I will need help breathing after my surgery.I have had a liver transplant or my liver disease is moderate to severe.
- Group 1: Melatonin
- Group 2: Placebo Group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the main goals of this experiment?
"The primary endpoint of this medical trial, which will span approximately 3 months, is to monitor the rate of recruitment. Secondary objectives include assessing the severity of delirium using the Confusion Assessment Method (CAM) severity form, measuring ICU care requirements during hospitalization and recording presence or absence of delirium through utilization of either CAM-short form or CAM-ICU tool depending on whether a patient is mechanically ventilated."
What is the current enrollment for this clinical trial?
"Affirmative. The clinicaltrial.gov website states that this trial is currently enrolling patients, with the initial listing posted on September 14th 2021 and last updated October 1st 2021. In total, 120 participants are being sought from two different study sites."
Are there any new opportunities to partake in this research?
"According to the clinicaltrials.gov database, this clinical trial is presently engaging in participant recruitment efforts; the initial post was made on September 14th of 2021 and a subsequent update was issued one month later."
Share this study with friends
Copy Link
Messenger